A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for
curative treatment in form of resection or transplantation. There are different treatment …

Yttrium-90 microspheres are radioactive particles which are increasingly being employed for
treating patients with unresectable hepatocellular carcinoma (HCC). The procedure is called …

Background Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver
that most commonly presents late in the disease course. As a result, the majority of patients …

Aim: Several techniques for radionuclide therapy of hepatocellular carcinoma (HCC) have
been developed. In this overview the available radionuclide treatment modalities for HCC …

Background Selective internal radiation therapy (SIRT) with yttrium-90 resin (Y-90 resin)
microspheres has been used as a locoregional therapy for patients with unresectable …

Abstract Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver
malignancies, and clinical data supporting its use have accumulated in recent years. Y90 …

To present a critical review of yttrium-90 (TheraSphere) for the treatment of hepatocellular
carcinoma (HCC). Medical literature databases (Medline, Cochrane Library, and …

Radioembolization has been demonstrated to allow locoregional therapy of patients with
hepatocellular carcinoma not eligible for transarterial chemoembolization or other local …

Background: Many patients with liver malignancies are not candidates for resection, and
systemic therapies are often not effective. Radioembolization (RE) is an alternative treatment …

Trans hepatic arterial radioembolotherapy using yttrium-90 microspheres represents in situ
therapy in hepatocellular cancer, which is the third leading cause of cancer-related deaths in …